Literature DB >> 7540265

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species.

C F Brosnan1, B Cannella, L Battistini, C S Raine.   

Abstract

The relative levels and cellular distribution of proinflammatory and regulatory cytokines have been examined by immunohistochemistry in multiple sclerosis (MS) lesions of differing activity and compared with CNS tissue from other neurologic diseases with an inflammatory or noninflammatory component. Results show widespread distribution of cytokines in association with both perivascular inflammatory cells and glial cells in all types of inflammatory lesions. Although no obvious pattern of proinflammatory versus regulatory cytokines could be determined in MS lesions, proinflammatory cytokines were rarely noted in normal and noninflammatory conditions, whereas regulatory cytokines were readily detectable in the same diseases. The possible relevance of these cytokine patterns to adhesion molecule expression and the presence of reactive nitrogen species is also addressed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540265     DOI: 10.1212/wnl.45.6_suppl_6.s16

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  48 in total

Review 1.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

2.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 4.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

5.  Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.

Authors:  Yong Chan Kim; Ai-Hong Zhang; Jeongheon Yoon; William E Culp; Jason R Lees; Kai W Wucherpfennig; David W Scott
Journal:  J Autoimmun       Date:  2018-05-30       Impact factor: 7.094

6.  Hyperfibrinogenemia-mediated astrocyte activation.

Authors:  Vincent D Clark; Ailey Layson; Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Brain Res       Date:  2018-08-25       Impact factor: 3.252

7.  Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.

Authors:  Paul D Storer; Jihong Xu; Janet A Chavis; Paul D Drew
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

Review 8.  The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain.

Authors:  Paul N Moynagh
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

Review 9.  Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Brain Pathol       Date:  2014-11       Impact factor: 6.508

10.  Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system.

Authors:  C E Thomson; M McCulloch; A Sorenson; S C Barnett; B V Seed; I R Griffiths; M McLaughlin
Journal:  Eur J Neurosci       Date:  2008-09-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.